Disclaimer: This article has been developed and funded by Daiichi Sankyo. Daiichi Sankyo has more than 120 years of experience and scientific expertise. In 2019, they entered the oncology market ...

It later transferred to the publisher Houbunsha, which began publishing the manga in volumes. So far, the manga's 4-panel chapters, while immense in numbers, have amounted to 116 volumes, with more to ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

Dai-Ichi Karkare Limited (DIKL) was set up in 1960 as a private limited company for the manufacture of speciality chemicals. The Company entered into technical collaboration with the ...

Dai­ichi Sankyo is spend­ing $132.5 mil­lion to buy an an­ti­body out­right that it had al­ready li­censed from Gly­co­tope.

Ichi the Witch has only been serializing for months, but despite that, it has become one of the most popular manga titles. It is the result of a combination of manga quality and endorsements from ...

Daiichi Sankyo is turning to the German city of Heidelberg for help developing antibodies. The Japanese pharma giant is teaming up with independent research institute BioMed X to form a new ...

TOKYO & BASKING RIDGE, N.J., January 13, 2025--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property ...